A cross-sectional magnetic resonance imaging assessment of organ specific hemosiderosis in 180 thalassemia major patients in Hong Kong

Haematologica

Volumn 93, Issue 5, 2008, Pages 784-786

  Au, Wing Yan ^a   Lam, Wynnie Wai Man ^f   Chu, Winnie ^f   Yuen, Hui Leung ^b   Ling, Alvin Siu Cheung ^c   Li, Rever Chak Ho ^d   Chan, Helen Man Hong ^b   Lee, Harold Kwok Kuen ^c   Law, Man Fai ^d   Liu, Herman Sung Yu ^e   Liang, Raymond ^a   Ha, Shau Yin ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^c PRINCESS MARGARET HOSPITAL   (Hong Kong)

^d TUEN MUN HOSPITAL   (Hong Kong)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^f Queen Mary Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; CONTROLLED STUDY; FEMALE; HEMOSIDEROSIS; HONG KONG; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; SCHOOL CHILD; THALASSEMIA;

ADOLESCENT; ADULT; ALGORITHMS; BETA-THALASSEMIA; CHILD; FEMALE; HEMATOLOGY; HEMOSIDEROSIS; HONG KONG; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PANCREAS; PITUITARY GLAND;

EID: 43449124144     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12367     Document Type: Letter

References (12)

1. Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, et al. Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major. Blood 2006;107:3733-7.
2. Tanner MA, He T, Westwood MA, Firmin DN, Pennell DJ. Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. Haematologica 2006;91:1388-91.
3. Au WY, Lam WWM, Chu W, Tam S, Wong WK, Pennell DJ, et al. A magnetic resonance imaging (MRI) study of iron overload in haemopoietic stem cell transplantation recipients with increased ferritin levels. Transplant Proceed 2007;39:3369-74.
4. Lam WWM, Au WY, Chu WCW, Tam S, Ha SY. MRI assessment of the pituitary gland in thalassaemia major. J Neuro Imaging 2008; (submitted).
5. Tanner MA, Galanello R, Dessi C, Westwood MA, Smith GC, Nair SV, et al. Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Cardiovasc Magn Reson 2006;8:543-7.
6. Neufeld EJ. Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions. Blood 2006;107:3436-41.
7. Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 1994;331:567-73.
8. Aessopos A, Fragodimitri C, Karabatsos F, Hatziliami A, Yousef J, Giakoumis A, et al. Cardiac magnetic resonance imaging R2* assessments and analysis of historical parameters in patients with transfusion-dependent thalassemia. Haematologica 2007;92:131-2.
9. Monge L, Pinach S, Caramellino L, Bertero MT, Dall'omo A, Carta Q. The possible role of autoimmunity in the pathogenesis of diabetes in β-thalassemia major. Diabetes Metabol 2001;27:149-54.
10. Christoforidis A, Haritandi A, Perifanis V, Tsatra I, Athanassiou-Metaxa M, Dimitriadis AS. MRI for the determination of pituitary iron overload in children and young adults with β-thalassaemia major. Eur J Radiol 2007;62:138-42.
11. Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, et al. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation 2007;115:1876-84.
12. Pennell DJ, Berdoukas V, Karagiorga M, Ladis V, Piga A, Aessopos A, et al. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood 2006;107:3738-44.